Methods | Individual randomised controlled trials | |
Participants | Dx: SD and dandruff (physician dx implied from text) Excluded: pregnant or breastfeeding Male: beta (50%), keto (46%); age: beta (47 ± 16 years), keto (40 ± 17 years); duration: beta (11 months), keto (17 months) |
|
Interventions | Intervention: 0.1% betamethasone lotion applied twice daily (week 1), once daily (week 2), twice weekly (weeks 3 and 4) (n = 34) Control: 2% ketoconazole hydrogel applied twice weekly for 4 weeks (n = 35) |
|
Outcomes | Global evaluation of cure, symptom score for scaling and pruritus | |
Notes | Country: The Netherlands; multi-centre study Financial support by Glaxo; adverse effect: folliculitis |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | "... randomly allocated..." |
Allocation concealment (selection bias) | High risk | "... randomly allocated..." |
Baseline comparable? | Low risk | Age, sex and severity |
Patient blinded? | High risk | Not reported |
Provider blinded? | High risk | Not reported |
Outcome assessor blinded? | High risk | Not reported |
Co-interventions avoided? | Low risk | Not allowed |
Compliance acceptable? | Unclear risk | Not reported |
Drop-out acceptable? | Low risk | Beta (5/34), keto (3/35) |
Selective outcome reporting acceptable? | Low risk | All outcomes reported |
ITT? | Unclear risk | Not reported |